Vascular Diseases Clinical Trial
Official title:
Can Remote Photoplethysmography Be Used for Contactless Vital Sign Acquisition in a Healthcare Setting? A Prospective Comparative Study.
Contactless and widely available health monitoring technologies are of growing interest in
the context of the worldwide COVID-19 pandemic. Remote photoplethysmography (rPPG) is a
well-studied technology that interprets variations in skin colour related to blood flow
which, when analysed with complex mathematical algorithm, generates vital sign readings. This
technology has been refined and embedded in a smartphone app designed to acquire heart rate,
respiratory rate and oxygen saturation using a front-facing smartphone camera.
Preliminary data comparing the accuracy of smartphone rPPG readings with conventional vital
sign monitor readings are promising; however, less than 5% of the population studied in the
app development phase had oxygen saturation levels below 95% making it impossible to ensure
reliability in these populations.
The goal of this study is to compare readings acquired using this rPPG app with the readings
from hospital grade, Health Canada approved vital signs monitors used in healthcare settings
with a focus on subject with low oxygen saturations. We will also study other
sociodemographic and clinical features that may influence the accuracy of the readings. This
will be achieved by recruiting consenting adults presenting to care in acute care settings
and a designated COVID outpatient clinic. Vital signs will be acquired using the rPPG app and
conventional hospital vital sign monitors simultaneously. Readings will be repeated within
2-5 minutes when time permits. Statistical analysis will be performed to analyze the findings
and determine the accuracy and precision of the rPPG app readings.
It is expected that the vital sign readings acquired with the rPPG app will be almost
identical to those acquired using hospital-grade monitors for all subjects regardless of age,
gender, skin colour, COVID status and relevant comorbidities.
Status | Not yet recruiting |
Enrollment | 350 |
Est. completion date | November 30, 2020 |
Est. primary completion date | October 30, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Persons willing to participate and capable of providing informed consent, age of 18 years of more. - Person able to sit still for the duration of the reading (maximum 2 minutes per reading). - Persons with freckles, discreet skin pigmentation changes Exclusion Criteria: - Unable to provide informed consent - Persons who are unable to follow basic instructions due to altered mental status, delirium, dementia or other conditions. - Age < 18 - Intubated patients and patients requiring masks for supplemental oxygen - Persons refusing to remove masks, eyewear, or clothing obstructing the face for the duration of readings. - Persons with facial tattoos, large birthmarks or other skin alterations (scars, hemangiomas) on their nose or upper cheeks (cheekbones). |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Lady Davis Institute | Carebook Technologies Inc. |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Accuracy of rPPG readings by oxygen saturation level | Analysis of accuracy of rPPG vital sign readings when stratified by oxygen saturation per conventional monitors stratified as follows: 95-100%; 90-94%; 85-89%; Less than 85% | immediate; stratified analysis | |
Other | Accuracy of rPPG readings by skin colour | Analysis of accuracy of rPPG vital sign readings when stratified by skin colour per the Fitzpatrick scale | immediate; stratified analysis | |
Other | Accuracy of rPPG readings by gender | Analysis of accuracy of rPPG vital sign readings when stratified for gender | immediate; stratified analysis | |
Other | Accuracy of rPPG readings by age | Analysis of accuracy of rPPG vital sign readings when stratified by age group | immediate; stratified analysis | |
Other | Accuracy of rPPG readings by comorbidity | Analysis of accuracy of rPPG vital sign readings when stratified for COVID, respiratory conditions, cardiac conditions and vascular conditions. | immediate; stratified analysis | |
Primary | Accuracy of rPPG heart rate | Accuracy of rPPG heart rate compared to conventional vital sign monitor heart rate readings. Comparison of each paired reading. | immediate; paired reading | |
Primary | Accuracy of rPPG oxygen saturation | Accuracy of rPPG oxygen saturation compared to conventional vital sign monitor oxygen saturation readings. Comparison of discrepancy within each paired reading set. | immediate; paired reading | |
Primary | Accuracy of rPPG respiratory rate | Accuracy of rPPG respiratory rate compared to manual counting of respiratory rate over 60 seconds. Comparison of discrepancy within each paired reading set. | immediate; paired reading | |
Secondary | Reproducibility of rPPG heart rate readings | Comparison of rPPG heart rate results obtained on a given patient on serial readings within 2 minutes of each other. | 2-5 minutes | |
Secondary | Reproducibility of rPPG oxygen saturation readings | Comparison of rPPG oxygen saturation results obtained on a given patient on serial readings within 2 minutes of each other. | 2-5 minutes | |
Secondary | Reproducibility of rPPG respiratory rate readings | Comparison of rPPG respiratory rate results obtained on a given patient on serial readings within 2 minutes of each other. | 2-5 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05971407 -
The Effect of Chronic Remote Ischaemic Preconditioning on Blood Pressure in Older Adults
|
N/A | |
Enrolling by invitation |
NCT03683186 -
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
|
Phase 3 | |
Recruiting |
NCT04390672 -
Multivessel TALENT
|
N/A | |
Recruiting |
NCT04584632 -
The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery
|
N/A | |
Completed |
NCT01915368 -
Determining Optimal Post-Stroke Exercise (DOSE)
|
N/A | |
Completed |
NCT01684826 -
X-ray Dose Reduction Study for Cardiac Angiography and Intervention
|
N/A | |
Completed |
NCT01417910 -
Predictors of Post Operative Outcome in Peripheral Vascular Surgical Patients
|
N/A | |
Terminated |
NCT00935766 -
Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries
|
Phase 3 | |
Unknown status |
NCT01748383 -
The Long-term and Short-term Efficacy and Safety of Transplantation Autologous Bone Marrow Cells (BMCs) in Patients With the First STEMI (ST Segment Elevation Myocardial Infarction)
|
Phase 2 | |
Recruiting |
NCT05907564 -
Aventus Thrombectomy System Pulmonary Embolism Clinical Study
|
N/A | |
Recruiting |
NCT03732612 -
Inflammation in Vascular Disease
|
||
Completed |
NCT00000614 -
Prevention of Recurrent Venous Thromboembolism (PREVENT)
|
Phase 3 | |
Completed |
NCT00000539 -
Arterial Disease Multifactorial Intervention Trial (ADMIT)
|
Phase 3 | |
Completed |
NCT00000530 -
Raynaud's Treatment Study (RTS)
|
Phase 3 | |
Completed |
NCT00000479 -
Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer
|
Phase 3 | |
Completed |
NCT00000474 -
Prevention and Treatment of Hypertension Study (PATHS)
|
Phase 3 | |
Completed |
NCT00000528 -
Trials of Hypertension Prevention (TOHP)
|
Phase 3 | |
Completed |
NCT00000509 -
Potassium and Sodium to Control Blood Pressure in Hypertensives
|
Phase 3 | |
Completed |
NCT00000501 -
Hypertension Prevention Trial (HPT) Feasibility Study
|
Phase 2 | |
Completed |
NCT00000499 -
Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study)
|
Phase 2 |